Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells | Zendy

Silvia Arpicco | Zendy; Giuseppe De Rosa | Zendy; Elias Fattal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells

Author(s) -

Silvia Arpicco,

Giuseppe De Rosa,

Elias Fattal

Publication year - 2013

Publication title -

journal of drug delivery

Language(s) - English

Resource type - Journals

eISSN - 2090-3014

pISSN - 2090-3022

DOI - 10.1155/2013/860780

Subject(s) - hyaluronic acid , cd44 , extracellular matrix , glycosaminoglycan , cancer cell , chemistry , haematopoiesis , microbiology and biotechnology , cancer , cancer research , biology , biochemistry , stem cell , in vitro , anatomy , genetics

Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan that exists in living systems, and it is a major component of the extracellular matrix. The hyaluronic acid receptor CD44 is found at low levels on the surface of epithelial, haematopoietic, and neuronal cells and is overexpressed in many cancer cells particularly in tumour initiating cells. HA has been therefore used as ligand attached to HA-lipid-based nanovectors for the active targeting of small or large active molecules for the treatment of cancer. This paper describes the different approaches employed for the preparation, characterization, and evaluation of these potent delivery systems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research